Notice NOT-HL-24-031 from the NIH Guide for Grants and Contracts

Notice NOT-HL-24-030 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-25-014 from the NIH Guide for Grants and Contracts. NIA seeks to support investigator-initiated research in low- and middle-income countries (LMICs)LMICs through two new notices of funding opportunity (NOFOs), Consortium for Neuroscience AD/ADRD in Low-and Middle-income Countries and the Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research. The creation of these new global health consortia in LMICs will require strong and robust coordination support. The U24 Cooperative Research Agreement will be utilized to support one Coordination Center to provide coordination and support for the consortia. Specifically, the U24 Coordination Center will: -Serve as an administrative and coordinating center for the consortia. . -Coordinate collaboration and communication efforts across the consortia, and lead outreach efforts. -Coordinate data sharing according to NIH data sharing policies and FAIR principles and subsequent dissemination of these resources to the wider scientific community.

Notice NOT-DK-24-036 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-26-002 from the NIH Guide for Grants and Contracts. The George M. O'Brien Urology Research Centers (U54) and Exploratory Centers for Interdisciplinary Research in Benign Urology (P20) serve to advance the NIDDKs mission to support highly meritorious, innovative, interdisciplinary research in benign urologic diseases and disorders, and the training of the next generation of researchers. Critical to these broad goals is the ability to promote productive interactions between the U54 and P20 Centers, the institutional career development programs (K12), and the broader urology research and clinical communities. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for a new Urology Centers Program Interactions Core (U24). The Interactions Core will serve as focal point for establishing productive collaborations within the Urology Centers Programs and between these Programs and other NIDDK urology training and scientific efforts and the broader research and clinical communities.

Gilead Sciences, Inc.: Intern Clinical Development, Bioinformatics United States - California - Foster City Gilead Sciences, Inc. is a research-based bio-pharmaceutical c... San Mateo, California

Gilead Sciences, Inc.: Intern Bioinformatics United States - California - Foster City Gilead Sciences, Inc. is a research-based bio-pharmaceutical company that discovers,... San Mateo, California

Avidity Biosciences: Job Title: Scientist, Bioinformatics Location: San Diego, CA / Hybrid Position type: FLSA: Full time Exempt Department: Finance ID: Development Sci... San Diego, California

Gilead Sciences, Inc.: Sr Research Scientist I, Bioinformatics Biologics Discovery United States - California - Foster City Gilead Sciences, Inc. is a research-based bio-... San Mateo, California

Emory University: Discover Your Career at Emory University: Emory University is a leading research university that fosters excellence and attracts world-class talent... Atlanta, Georgia, Working from home

Eikon Therapeutics: Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation... Hayward, California

Notice NOT-CA-24-098 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-380 from the NIH Guide for Grants and Contracts

Notice NOT-GM-24-054 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-103 from the NIH Guide for Grants and Contracts

Substantial start-up package and attractive salary: Institute of Science and Technology Austria (ISTA): ISTA invites for faculty applications in Chemistry, Computer Science, Data Science, Earth Science, Life Sciences, Mathematics, and Soft Matter Phys... Klosterneuburg, Austria

Notice NOT-CA-24-099 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-24-255 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Small Business Concerns (SBCs) holding Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctoral scholars, and eligible investigators from groups that have been shown to be nationally underrepresented in health-related research or in the SBIR and STTR programs. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project. This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this NOFO are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Negotiable: Oxford Nanopore Technologies: We are looking for a highly motivated Applied and Regulated Development scientist with good lab-based skills to join our Applied and Regulated Development team. Oxford, England

Funding Opportunity RFA-DA-25-073 from the NIH Guide for Grants and Contracts. This broad RFA will support exploratory studies addressing mechanistic questions in HIV infection, replication, latency, and/or pathogenesis (including HAND) in the context of SUDs.